Lumoptik
Spring Grove
About Lumoptik
Lumoptik has developed a light-based needle guidance platform technology with many high value medical uses. The company's first product is a needle guidance system for epidural procedures. There are over 11 million epidurals performed in the US. The system is inexpensive and easy to use. Razor and razor blade commercial model with an electronic controller (razor) and disposable sterile fiber optic (razor blade). We have the commercial version in production for clinical trials and have met with the FDA. Product launch is planned for mid 2021. We have also performed a proof-of-concept animal trial for an orthopedic system to guide placement of pedicle screws during spine surgeries. This is our second product in the platform technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $900.0K
- Funding stage: Seed
- Last round: Seed (Jun 2022)
- Website: lumoptik.com
- Phone: 630-561-5897
Industries & Categories
Health Care, Medical, Medical Device
Canonical: https://fsome.com/organization/lumoptik-4851 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.